Abbott Laboratories

General Motors Executive Vice President Global Manufacturing and Labor Relations Gerald Johnson (middle) watches as engineers and technicians set-up and test the machines that will be used to manufacture Level 1 face masks at a plant in Warren, Michigan.Photo by John F. Martin for General MotorsDETROIT – General Motors' long-time head of manufacturing is retiring, and the company has hired a former Tesla and Google executive to fill his shoes.The Detroit automaker said on Tuesday that Gerald Johnson, executive vice…

Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021.Dado Ruvic | ReutersAbbVie on Tuesday said longtime executive Robert Michael will become the company's new CEO, replacing Richard Gonzalez. Michael, who is AbbVie's president and chief operating officer, will become the company's second-ever CEO on July 1. Gonzalez, who has led the company since it spun out from Abbott Laboratories in 2013, will retire and become AbbVie's executive chairman. The announcement marks an end to…

We don't know what we want. This week, we will find out what it is that will propel us forward or turn us back after the S & P 500 on Friday closed at a new record high for the first time in more than two years. For example, we have three rails that report this week: Union Pacific , CSX and Norfolk Southern . Among them, you have pretty much every non-service portion of the U.S. economy spoken for: housing, industrial production, minerals, road building, heating, and food. What kinds of numbers do we want from these…

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021.David W. Cerny | ReutersThe health-care sector has wiped out much of its losses for the year during the December market rally. Beaten-down biotech and medical device makers have seen the biggest rebound this month, and analysts see that momentum continuing in the new year.Still, analysts and strategists have a mixed outlook for the sector in 2024."We're entering the year as an underweight," said Sam Stovall,…

Sopa Images | Lightrocket | Getty ImagesPfizer's twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences. The drugmaker on Friday said it will stop developing the twice-daily treatment, danuglipron, after obese patients taking the drug lost significant weight but experienced high rates of adverse side effects in a midstage clinical trial. Pfizer noted that it will release data on a once-daily version of…

The average selling prices of toothbrushes, infant formula and makeup are declining as businesses adapt to circumstances. The average selling prices of toothbrushes, infant formula and makeup are declining as businesses adapt to circumstances. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all…

The agency is investigating whether any formula manufacturers coordinated before bidding for state contracts. The agency is investigating whether any formula manufacturers coordinated before bidding for state contracts. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors.…

(L-R) Richard A. Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of the board and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, executive vice president and worldwide chairman of Janssen Pharmaceuticals, Johnson & Johnson, Kenneth C. Frazier, chairman and CEO of Merck & Co. Inc., Albert Bourla, CEO of Pfizer, and Olivier Brandicourt, CEO of Sanofi testify in front of the Senate Finance Committee on 'Drug Pricing in America: A…

WASHINGTON—The baby-formula industry remains as vulnerable to safety problems and supply disruptions as it did more than a year ago, when a recall led to nationwide shortages, a former Food and Drug Administration official says in testimony submitted for a congressional hearing Tuesday.  “The nation remains one outbreak, tornado, flood, or cyberattack away from finding itself in a similar place to that of February 17, 2022,” Frank Yiannas, the former…

Image: David McNew (Getty Images)Apple is reportedly close to creating a noninvasive glucose test for diabetics through a new sensor on its Apple Watch. The technology has been in the works since 2010, when then-Apple CEO and founder Steve Jobs bought out RareLight, a small startup that crafted ideas for noninvasive blood glucose monitoring.The technology may still be years away, but if it is approved, sources told Bloomberg it will measure diabetics’ glucose levels but could also be used as a preventative measure, with…